The global legal marijuana market size is expected to reach USD 84.0 billion by 2028, according to a new report by Grand View Research, Inc. This market is expected to expand at a CAGR of 14.3% from 2021 to 2028. Increased legalization of marijuana for medical and adult-use and the growing adoption of these products for the treatment of chronic diseases are the key factors driving the market for legal marijuana.
The adult-use segment dominated the market with a revenue share of 60.3% in 2020 and is expected to expand at a significant CAGR over the forecast period owing to the high demand among millennials and patients who do not qualify for medical cannabis. Medical marijuana is expected to grow at a stable rate throughout the forecast period owing to the legalization in various markets as compared to the adult use of marijuana.
Based on product type, the flower segment accounted for the largest revenue share in 2020. With its rich medical properties and the increasing patient population, the governments of many countries are either decriminalizing or approving its usage. This is expected to boost the growth of the flower segment.
In 2020, the chronic pain segment accounted for the largest revenue share owing to the increase in awareness and a rise in social acceptance of medical use of cannabis. The mental disorder segment is estimated to witness the fastest growth over the forecast period owing to the rising patient population suffering from stress and anxiety.
North America accounted for the largest revenue share of 91.1% in 2020, owing to the early legalization of medical and recreational cannabis in the region and the large customer pool. However, the COVID-19 pandemic has caused lockdowns all around the world, deflating the supply of raw materials and disrupting the manufacturing, and in turn, the supply chain of cannabis products across the globe.
Request a free sample copy or view report summary: Legal Marijuana Market Report
Based on marijuana type, the adult-use segment accounted for the largest share of 60.3% in 2020 owing to high demand among millennials and patients who do not qualify for medical cannabis
In 2020, the flower product type segment accounted for the largest revenue share of 65.8% owing to the low price and ease of accessibility of flowers compared to other products
By medical application, the mental disorders segment is expected to witness the fastest growth over the forecast period owing to the high number of people suffering from various mental disorders
Grand View Research has segmented the global legal marijuana market based on marijuana type, product type, medical application, and region:
Legal Marijuana Type Outlook (Revenue, USD Million, 2016 - 2028)
Medical
Adult Use
Legal Marijuana Product Type Outlook (Revenue, USD Million, 2016 - 2028)
Flower
Oil
Legal Marijuana Medical Application Outlook (Revenue, USD Million, 2016 - 2028)
Chronic Pain
Mental Disorders
Cancer
Others
Legal Marijuana Regional Outlook (Revenue, USD Million, 2016 - 2028)
U.S.
Canada
U.K.
Germany
Italy
Netherlands
Croatia
Poland
Czech Republic
Switzerland
Spain
Australia
New Zealand
Thailand
Uruguay
Colombia
Mexico
Chile
Argentina
Israel
List of Key Players of Legal Marijuana Market
Aurora Cannabis
Canopy Growth Corporation
Maricann Group, Inc.
Aphria, Inc.
Tilray
The Cronos Group
ABcann Medicinals, Inc.
Lexaria Corp.
Organigram Holding, Inc.
This report has a service guarantee. We stand by our report quality.
Your transaction & personal information is safe and secure.
Design an exclusive study to serve your research needs.
Get your queries resolved from an industry expert.
Avail customized purchase options to meet your research needs:
"The quality of research they have done for us has been excellent..."